JPMorgan Chase & Co. Purchases 102,982 Shares of Maximus, Inc. (NYSE:MMS)

JPMorgan Chase & Co. lifted its holdings in Maximus, Inc. (NYSE:MMS) by 46.0% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 326,748 shares of the health services provider’s stock after acquiring an additional 102,982 shares during the period. JPMorgan Chase & Co. owned approximately 0.57% of Maximus worth $24,392,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of the business. Nordea Investment Management AB acquired a new position in shares of Maximus during the 4th quarter worth approximately $4,618,000. Fort Washington Investment Advisors Inc. OH grew its position in Maximus by 39.1% during the fourth quarter. Fort Washington Investment Advisors Inc. OH now owns 296,476 shares of the health services provider’s stock worth $22,132,000 after buying an additional 83,390 shares in the last quarter. IFP Advisors Inc increased its stake in Maximus by 62.4% during the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider’s stock worth $59,000 after acquiring an additional 302 shares during the period. Mirae Asset Global Investments Co. Ltd. acquired a new position in Maximus in the 4th quarter valued at $1,113,000. Finally, Legato Capital Management LLC lifted its position in shares of Maximus by 33.9% during the 4th quarter. Legato Capital Management LLC now owns 32,134 shares of the health services provider’s stock valued at $2,399,000 after acquiring an additional 8,138 shares during the period. 97.21% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research analysts recently commented on the company. Raymond James upgraded Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price target on the stock in a research report on Thursday, January 2nd. StockNews.com cut shares of Maximus from a “buy” rating to a “hold” rating in a research report on Friday, February 14th.

Insider Transactions at Maximus

In related news, Director Jan Madsen sold 2,439 shares of the stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the sale, the director now directly owns 18,097 shares in the company, valued at $1,225,347.87. This represents a 11.88 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Ilene R. Baylinson sold 14,500 shares of the firm’s stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the transaction, the insider now directly owns 2,512 shares of the company’s stock, valued at approximately $171,167.68. This represents a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.60% of the company’s stock.

Maximus Trading Up 3.5 %

Shares of MMS opened at $67.85 on Thursday. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. Maximus, Inc. has a 52-week low of $63.77 and a 52-week high of $93.97. The firm has a market cap of $3.84 billion, a price-to-earnings ratio of 14.59 and a beta of 0.68. The business’s fifty day moving average is $68.20 and its 200-day moving average is $76.49.

Maximus (NYSE:MMS) last issued its earnings results on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Equities analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th will be paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.77%. The ex-dividend date of this dividend is Thursday, May 15th. Maximus’s payout ratio is 25.81%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.